General
publicado em 25/09/2012 às 16h36:00
   Dê o seu voto:

Activists advocating greater access to new drugs against hepatitis C

"The product is good and necessary, but we are unable to handle a very large number of patients," says NGO

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



The government's decision to prioritize the use of new drugs against Hepatitis C Boceprevir and telaprevir for patients with cirrhosis or advanced stage of fibrosis is criticized by activists in the area. They would like all patients to access treatment because the drug increases the chances of curing the disease.

Carlos piercing, chairman of Optimism Group support for patients with hepatitis, believes that the distribution of the drug for these groups will generate a series of lawsuits from other patients who also want access to it: The medicine is good and necessary, but we are unable to handle a very large number of patients and this creates a huge problem. The contemplated will not act and are acting judicially, either against the state or against health plans. Better that these actions were not necessary, but if this is what will ensure the treatment of other patients, then I am in favor, said.

The coordinator of the Brazilian carriers of Hepatitis, Virginia Alves, agrees. According to her, there is a big delay for patients receiving the medication, even those within the recommendation and already have cirrhosis, and this is leading to the lawsuits. According to the activist, the medication should be universal and not restricted to patients with a framework already advanced. The sooner you start treatment, the better the chance of cure and treatment is faster, commented.

Jehovah Pessin Fragoso, coordinator of the Hope Group, Santos believes that the prescription drug is valid and brings a great hope for us, but there is no medical consensus regarding its use restricted only to cirrhotic patients, he said. Why should we expect the disease evolve to take this medicine? , Questions.

According to Jehovah, one of the paths taken by civil society was a petition that collected signatures for the Prevention of Congress in São Paulo, which called for a reduction in the price of Boceprevir and telaprevir. With lower prices, they believe the treatment could reach more patients.

Moreover, it is also interesting that the government invests in research on the subject, especially those concerning the use of this drug has not yet whom cirrhosis, finished.

Source: AGENCIA AIDS
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Activists advocating greater access to new drugs against hepatitis C
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Activists advocating greater access to new drugs against hepatitis C


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
Hepatitis C    drug Boceprevir    Telaprevir    Group Optimism    Brazilian Association of patients with hepatitis   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.